# Acorn Capital Advisors, LLC 13F holdings

> Latest reported SEC 13F equity book. Teaser: top 10 of 22 long-equity positions.
> CIK 2054410. Latest filing Q1 2026, as of quarter end 2026-03-31. Long-equity book $351.8M.

## Top holdings (teaser)

| # | Ticker | Issuer | Value | % of book | Change |
|---|--------|--------|-------|-----------|--------|
| 1 | n/a | Terns Pharmaceuticals Inc | $92.1M | 26.2% | Held |
| 2 | n/a | CG Oncology Inc | $76.6M | 21.8% | Reduced |
| 3 | n/a | Urogen Pharma Ltd | $30.1M | 8.6% | Added |
| 4 | PBYI | Puma Biotechnology Inc | $26.4M | 7.5% | Held |
| 5 | n/a | Trevi Therapeutics Inc | $25.6M | 7.3% | Held |
| 6 | n/a | Candel Therapeutics Inc | $17.2M | 4.9% | Added |
| 7 | n/a | Bicara Therapeutics | $12.8M | 3.6% | Held |
| 8 | n/a | Onkure Therapeutics Inc | $11.8M | 3.3% | Held |
| 9 | JBIO | Jade Biosceinces Inc | $11.1M | 3.1% | New |
| 10 | n/a | Protara Therapeutics Inc | $9.1M | 2.6% | Held |

## Latest moves

Bought: JBIO, Karyopharm Therapeutics Inc, Urogen Pharma Ltd
Sold: CG Oncology Inc, Helus Pharma Inc., Cardif Oncology Inc

Counts and totals reflect the 13F filers and securities Arkolith tracks, not the entire institutional universe. Option legs are excluded from the book above.

## Full data via the API and MCP

This page is a teaser. The complete book, full quarter-over-quarter history, and per-datapoint
provenance are available through the metered REST API and MCP server.

- Endpoint: https://arkolith.com/api/mcp (transport: streamable-http)
- Auth: Bearer API key. Mint one and copy a ready-to-paste command at https://arkolith.com/connect
- Claude Code: `claude mcp add --transport http arkolith https://arkolith.com/api/mcp --header "Authorization: Bearer YOUR_API_KEY"`
- Discovery: `tools/list` is free; `tools/call` is metered by credits.

### Machine-readable
- Tool catalog JSON: https://arkolith.com/api/mcp/catalog
- MCP descriptor: https://arkolith.com/.well-known/mcp.json
- OpenAPI 3.1 REST spec: https://arkolith.com/openapi.json
- Full LLM guide: https://arkolith.com/llms-full.txt
- Human docs: https://arkolith.com/docs

## Source and method

- Source: SEC EDGAR 13F-HR (public domain). Long-equity positions only (option legs excluded). Filed quarterly, about a 45-day lag.
- Primary source: https://www.sec.gov/Archives/edgar/data/2054410/000163658726000029/
- Human page: https://arkolith.com/fund/acorn-capital-advisors-llc-2054410
- Per-datapoint lineage: call the `provenance.get` MCP tool for the source URL and fetch history behind any figure.

Paid product with a one-time evaluation grant at signup (no card to evaluate). Most calls cost 1 credit (~$0.01); heavier point-in-time / cross-source tools cost more.

_Latest disclosed public filings. Data, not investment advice._